Thank you for sharing!

Your article was successfully shared with the contacts you provided.
Founded in 1990 by Lynn Bergeson and Lisa Campbell, D.C.-based,11-lawyer Bergeson & Campbell P.C. concentrates on chemical, medical device, and diagnostic product approval and regulation, and associated business issues. Bergeson & Campbell’s consulting affiliate, The Acta Group L.L.C., helps clients manage chemicals and medical products from concept to approval, using the skills and experience of professionals who have worked in the specific product areas in government and industry. Lynn Bergeson has practiced chemicals regulation, environmental, and occupational safety and health law since 1980 and represents individual corporations and a wide range of trade groups on chemical-specific legislative, regulatory, and enforcement-related matters. Lisa Campbell has practiced environmental law since 1985 and focuses on chemicals regulation and compliance matters and assists corporations and trade groups on these issues. Why did you decide to start your own practice? From its inception, Bergeson & Campbell has focused on responding to a demand for high-caliber legal and science-policy work involving industrial and agricultural chemical substances in a structure that provided the best potential vehicle for nimbly, efficiently, and effectively meeting client needs. We have been working together for many years; the firm is a natural outgrowth of both our long professional relationship and our work together over the years to provide the services for which our clients seek us out. Tell us about your clients. We serve the global industrial, agricultural, and specialty chemical sectors. Approximately half of our time is devoted to counseling clients on matters involving domestic and international chemical regulation and compliance, including products of biotechnology, chemical classification issues before the International Agency for Research on Cancer, the National Toxicology Program, the Environmental Protection Agency, and the European Union, and related chemical classification venues, and product advocacy and defense matters involving a wide range of domestic and international science policy and related matters. Approximately 40 percent of our time is devoted to agricultural, anti-microbial, biochemical, and related chemical matters arising under the Federal Insecticide, Fungicide, and Rodenticide Act or the Food Quality Protection Act on behalf of U.S.-based agricultural chemical or anti-microbial chemical producers, or off-shore producers seeking U.S. FIFRA registrations. A significant portion of the work done by our consulting affiliate, the Acta Group, is devoted to offshore chemical classification matters arising under, for example, EU and Pacific Rim registration matters. The remaining 10 percent of our time is devoted to the Food and Drug Administration and more traditional miscellaneous air, water, and waste matters. Where do you find your clients? Most of our business is either repeat business from longstanding firm clients, or referrals from existing clients. We also receive calls from potential new clients based on our reputation and visibility in the chemical community. A review of our Web site ( www.lawbc.com) reveals that our professionals write often and speak regularly at programs that focus on regulatory and science policy matters pertinent to the business sectors whose interests we serve. Bergeson & Campbell has been, for example, a sponsor for years of the American Chemistry Council/Synthetic Organic Chemical Manufacturers Association Global Chemical Regulations Conference, the premier conference for the chemical community. Lynn Bergeson serves on the editorial boards of five publications, is active in the American Bar Association Section of Environment, Energy, and Resources and will serve as its chair in 2005, and serves on the executive committee and board of directors of the Environmental Law Institute. Other Bergeson & Campbell professionals are likewise active in organizations serving the chemical community. How do you measure business success? We measure business success in terms of how well and efficiently we achieve our clients’ business goals and financial success by standard profitability measures. Based on the level of repeat business and independent measures of client success (winning cases, obtaining product approval, or reclassifying chemicals under various regulatory programs to minimize market barriers), our record is one we can be proud of. Our business has grown each year through disciplined fiscal management, low overhead, and competitive service pricing. Each of our attorneys and professionals has an annual target number of billable and nonbillable hours; we budget based on a percentage of this target, taking into account the experience of prior years. We structure our financial goals and the steps to achieve them to allow disciplined flexibility, which we have found to achieve results most effectively and efficiently. What challenges to your practice do you foresee in the future? Our key challenge is keeping up with the demands placed on our clients to ensure that their businesses continue to thrive. Due to the sophistication of detractors of the global chemical community, there is no dearth of regulatory and toxicological challenges facing our clients. For example, when there is public focus on a chemical product, whether warranted or not, the resource demands placed on a client can be staggering and the potential damage to that client’s markets devastating. Our job is to ensure our clients are well-prepared for and in the best possible position to prevent � and if not prevent, minimize � any of these negative impacts when such scrutiny turns to their products. Doing so effectively requires a combination of technical, legal, and political skills. Our challenge is to bring these skill sets together efficiently and effectively for our clients.

This content has been archived. It is available exclusively through our partner LexisNexis®.

To view this content, please continue to Lexis Advance®.

Not a Lexis Advance® Subscriber? Subscribe Now

Why am I seeing this?

LexisNexis® is now the exclusive third party online distributor of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® customers will be able to access and use ALM's content by subscribing to the LexisNexis® services via Lexis Advance®. This includes content from the National Law Journal®, The American Lawyer®, Law Technology News®, The New York Law Journal® and Corporate Counsel®, as well as ALM's other newspapers, directories, legal treatises, published and unpublished court opinions, and other sources of legal information.

ALM's content plays a significant role in your work and research, and now through this alliance LexisNexis® will bring you access to an even more comprehensive collection of legal content.

For questions call 1-877-256-2472 or contact us at [email protected]


ALM Legal Publication Newsletters

Sign Up Today and Never Miss Another Story.

As part of your digital membership, you can sign up for an unlimited number of a wide range of complimentary newsletters. Visit your My Account page to make your selections. Get the timely legal news and critical analysis you cannot afford to miss. Tailored just for you. In your inbox. Every day.

Copyright © 2020 ALM Media Properties, LLC. All Rights Reserved.